SCHEMBL29425148

SCHEMBL29425148

CCc1cc(F)cc2[nH]c(C(=O)O)cc12

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ EIF4A3 P38919 3/20 0.51
▸ KDM4E B2RXH2 3/20 0.49
▸ ALDH1A1 P00352 2/20 0.49
▸ LMNA P02545 2/20 0.49
▸ HPGD P15428 2/20 0.49
▸ HSD17B10 Q99714 2/20 0.49
▸ PDPK1 O15530 1/20 0.49
▸ TSHR P16473 1/20 0.49
▸ NFKB1 P19838 1/20 0.49
▸ APEX1 P27695 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ TDP1 Q9NUW8 1/20 0.49
▸ GRIN1 Q05586 1/20 0.45
▸ RHEB Q15382 4/20 0.44
▸ IDO1 P14902 3/20 0.43
▸ TDO2 P48775 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22394978 1.00 EIF4A3 (0.51) EIF4A3KDM4EALDH1A1LMNAHPGD
SCHEMBL29301286 0.87 KDM4E (0.49) EIF4A3KDM4EALDH1A1LMNAHPGD
SCHEMBL30147446 0.87 KDM4E (0.49) EIF4A3KDM4EALDH1A1LMNAHPGD
SCHEMBL30147558 0.83 KMT2A (0.43) EIF4A3KDM4EGRIN1
SCHEMBL22620764 0.83 ULK1 (0.46) EIF4A3KDM4EALDH1A1LMNAHPGD
SCHEMBL1144892 0.81 EIF4A3 (0.63) EIF4A3KDM4EALDH1A1LMNAHPGD
SCHEMBL29655546 0.81 EIF4A3 (0.63) EIF4A3KDM4EALDH1A1LMNAHPGD
SCHEMBL20505503 0.80 EIF4A3 (0.54) EIF4A3KDM4EALDH1A1LMNAHPGD
SCHEMBL29974750 0.80 EIF4A3 (0.54) EIF4A3KDM4EALDH1A1LMNAHPGD
SCHEMBL1957687 0.79 KDM4E (0.53) EIF4A3KDM4EALDH1A1LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4149945-A1 SUBSTITUTED TRICYCLIC AMIDES, ANALOGUES THEREOF, AND METHODS USING SAME Arbutus Biopharma Corporation (CA) 2023-03-22 — — EP disclosed
EP-3962914-A1 NOVEL INDOLE-2-CARBOXAMIDES ACTIVE AGAINST THE HEPATITIS B VIRUS (HBV) AiCuris GmbH & Co. KG (DE) 2022-03-09 — — EP disclosed
Send feedback